Cargando…
New developments in the treatment of metastatic gastric cancer: focus on trastuzumab
Patients with metastatic gastric cancer have a poor outcome. The development of new combinations of chemotherapy has led to steady but only modest gains in overall survival with largest effects reported with two- and three-drug regimens. Trastuzumab, a fully humanized monoclonal antibody directed at...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084304/ https://www.ncbi.nlm.nih.gov/pubmed/21552412 http://dx.doi.org/10.2147/OTT.S10188 |